Neurodegeneration in Parkinson's Disease: Interactions of Oxidative Stress, Tryptophan Catabolites and Depression with Mitochondria and Sirtuins

Overview

Journal Mol Neurobiol

Specialties Molecular Biology
Neurology

Date 2013 Oct 3

PMID 24085563

Citations 37

Authors

George Anderson

Michael Maes

Affiliations

Soon will be listed here.

Abstract

The biological underpinnings to the etiology and course of neurodegeneration in Parkinson's disease are an area of extensive research that has yet to produce an early biological marker or disease-slowing or preventative treatment. Recent conceptualizations of Parkinson's disease have integrated immuno-inflammation and oxidative and nitrosative stress occurring in depression, somatization and peripheral inflammation into the course of Parkinson's disease. We review the data showing the importance of immuno-inflammatory processes and oxidative and nitrosative stress in such classically conceived 'comorbidities', suggesting that lifetime, prodromal and concurrent depression and somatization may be intricately involved in the etiology and course of Parkinson's disease, rather than psychiatric comorbidities. This produces a longer term developmental perspective of Parkinson's disease, which incorporates tryptophan catabolites (TRYCATs), lipid peroxidation, sirtuins, cyclic adenosine monophosphate, aryl hydrocarbon receptor, and circadian genes. This integrates wider bodies of data pertaining to neuronal loss in Parkinson's disease, emphasizing how these interact with susceptibility genes to drive changes in mitochondria, blood-brain barrier permeability and intercellular signalling. We review this data here in the context of neurodegeneration in Parkinson's disease and to the future directions indicated for slowing disease progression.

Citing Articles

Interplay among Oxidative Stress, Autophagy, and the Endocannabinoid System in Neurodegenerative Diseases: Role of the Nrf2- p62/SQSTM1 Pathway and Nutraceutical Activation.

Armeli F, Mengoni B, Laskin D, Businaro R Curr Issues Mol Biol. 2024; 46(7):6868-6884.

PMID: 39057052 PMC: 11276139. DOI: 10.3390/cimb46070410.

The beneficial effect of fluoxetine on behavioral and cognitive changes in chronic experimental Chagas disease unveils the role of serotonin fueling astrocyte infection by Trypanosoma cruzi.

Vilar-Pereira G, Gibaldi D, Castano-Barrios L, da Silva A, Resende Pereira I, Cruz Moreira O PLoS Negl Trop Dis. 2024; 18(5):e0012199.

PMID: 38776344 PMC: 11149870. DOI: 10.1371/journal.pntd.0012199.

Comparing the effect of intravenous versus intracranial grafting of mesenchymal stem cells against parkinsonism in a rat model: Behavioral, biochemical, pathological and immunohistochemical studies.

Essawy A, Abou-ElNaga O, Mehanna R, Badae N, Elsawy E, Soffar A PLoS One. 2024; 19(2):e0296297.

PMID: 38349932 PMC: 10863851. DOI: 10.1371/journal.pone.0296297.

Identification of tryptophan metabolism-related genes in immunity and immunotherapy in Alzheimer's disease.

Song Z, Wu Z, Luo R, He C, Li Z, Yang M Aging (Albany NY). 2023; 15(22):13077-13099.

PMID: 37988184 PMC: 10713402. DOI: 10.18632/aging.205220.

A Comprehensive Review on Neuroimmunology: Insights from Multiple Sclerosis to Future Therapeutic Developments.

Eva L, Ples H, Covache-Busuioc R, Glavan L, Bratu B, Bordeianu A Biomedicines. 2023; 11(9).

PMID: 37760930 PMC: 10526343. DOI: 10.3390/biomedicines11092489.

References

Weir H, Murray T, Kehoe P, Love S, Verdin E, ONeill M . CNS SIRT3 expression is altered by reactive oxygen species and in Alzheimer's disease. PLoS One. 2012; 7(11):e48225. PMC: 3491018. DOI: 10.1371/journal.pone.0048225. View

Maes M, Mihaylova I, Kubera M, Leunis J, Geffard M . IgM-mediated autoimmune responses directed against multiple neoepitopes in depression: new pathways that underpin the inflammatory and neuroprogressive pathophysiology. J Affect Disord. 2011; 135(1-3):414-8. DOI: 10.1016/j.jad.2011.08.023. View

Xia J, Lim J, Lu W, Beckel J, Macarak E, Laties A . Neurons respond directly to mechanical deformation with pannexin-mediated ATP release and autostimulation of P2X7 receptors. J Physiol. 2012; 590(10):2285-304. PMC: 3424753. DOI: 10.1113/jphysiol.2012.227983. View

Maaetoft-Udsen K, Shimoda L, Frokiaer H, Turner H . Aryl hydrocarbon receptor ligand effects in RBL2H3 cells. J Immunotoxicol. 2012; 9(3):327-37. PMC: 3529589. DOI: 10.3109/1547691X.2012.661802. View

Laugeray A, Launay J, Callebert J, Surget A, Belzung C, Barone P . Peripheral and cerebral metabolic abnormalities of the tryptophan-kynurenine pathway in a murine model of major depression. Behav Brain Res. 2010; 210(1):84-91. DOI: 10.1016/j.bbr.2010.02.014. View

Marxreiter F, Regensburger M, Winkler J . Adult neurogenesis in Parkinson's disease. Cell Mol Life Sci. 2012; 70(3):459-73. PMC: 11113680. DOI: 10.1007/s00018-012-1062-x. View

Donmez G, Arun A, Chung C, McLean P, Lindquist S, Guarente L . SIRT1 protects against α-synuclein aggregation by activating molecular chaperones. J Neurosci. 2012; 32(1):124-32. PMC: 3263206. DOI: 10.1523/JNEUROSCI.3442-11.2012. View

Luchowska E, Kloc R, Olajossy B, Wnuk S, Wielosz M, Owe-Larsson B . beta-adrenergic enhancement of brain kynurenic acid production mediated via cAMP-related protein kinase A signaling. Prog Neuropsychopharmacol Biol Psychiatry. 2009; 33(3):519-29. DOI: 10.1016/j.pnpbp.2009.02.002. View

Hoglinger G, Rizk P, Muriel M, Duyckaerts C, Oertel W, Caille I . Dopamine depletion impairs precursor cell proliferation in Parkinson disease. Nat Neurosci. 2004; 7(7):726-35. DOI: 10.1038/nn1265. View

10.

Hartai Z, Klivenyi P, Janaky T, Penke B, Dux L, Vecsei L . Kynurenine metabolism in plasma and in red blood cells in Parkinson's disease. J Neurol Sci. 2005; 239(1):31-5. DOI: 10.1016/j.jns.2005.07.006. View

11.

Tanno M, Kuno A, Yano T, Miura T, Hisahara S, Ishikawa S . Induction of manganese superoxide dismutase by nuclear translocation and activation of SIRT1 promotes cell survival in chronic heart failure. J Biol Chem. 2010; 285(11):8375-82. PMC: 2832987. DOI: 10.1074/jbc.M109.090266. View

12.

Tavano F, di Mola F, Latiano A, Palmieri O, Bossa F, Valvano M . Neuroimmune interactions in patients with inflammatory bowel diseases: disease activity and clinical behavior based on Substance P serum levels. J Crohns Colitis. 2012; 6(5):563-70. DOI: 10.1016/j.crohns.2011.11.004. View

13.

Beaule C, Swanstrom A, Leone M, Herzog E . Circadian modulation of gene expression, but not glutamate uptake, in mouse and rat cortical astrocytes. PLoS One. 2009; 4(10):e7476. PMC: 2758999. DOI: 10.1371/journal.pone.0007476. View

14.

Silverman W, de Rivero Vaccari J, Locovei S, Qiu F, Carlsson S, Scemes E . The pannexin 1 channel activates the inflammasome in neurons and astrocytes. J Biol Chem. 2009; 284(27):18143-51. PMC: 2709345. DOI: 10.1074/jbc.M109.004804. View

15.

LeWitt P . Norepinephrine: the next therapeutics frontier for Parkinson's disease. Transl Neurodegener. 2012; 1(1):4. PMC: 3506997. DOI: 10.1186/2047-9158-1-4. View

16.

Kong X, Wang R, Xue Y, Liu X, Zhang H, Chen Y . Sirtuin 3, a new target of PGC-1alpha, plays an important role in the suppression of ROS and mitochondrial biogenesis. PLoS One. 2010; 5(7):e11707. PMC: 2908542. DOI: 10.1371/journal.pone.0011707. View

17.

Yoritaka A, Hattori N, Uchida K, Tanaka M, Stadtman E, Mizuno Y . Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc Natl Acad Sci U S A. 1996; 93(7):2696-701. PMC: 39693. DOI: 10.1073/pnas.93.7.2696. View

18.

Liu L, Arun A, Ellis L, Peritore C, Donmez G . Sirtuin 2 (SIRT2) enhances 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced nigrostriatal damage via deacetylating forkhead box O3a (Foxo3a) and activating Bim protein. J Biol Chem. 2012; 287(39):32307-11. PMC: 3463341. DOI: 10.1074/jbc.C112.403048. View

19.

Zhang A, Wang H, Qin X, Pang S, Yan B . Genetic analysis of SIRT1 gene promoter in sporadic Parkinson's disease. Biochem Biophys Res Commun. 2012; 422(4):693-6. DOI: 10.1016/j.bbrc.2012.05.059. View

20.

Maes M, Kubera M, Obuchowiczwa E, Goehler L, Brzeszcz J . Depression's multiple comorbidities explained by (neuro)inflammatory and oxidative & nitrosative stress pathways. Neuro Endocrinol Lett. 2011; 32(1):7-24. View